IIM
BBIO icon

INTECH Investment Management’s BridgeBio Pharma BBIO Stock Holding History

INTECH Investment Management’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-43,857
Closed -$3.26M – 2126
2026
Q1 		$3.26M Sell
43,857
-24,197
-36% -$1.75M 0.03% 488
2025
Q4 		$5.21M Hold
68,054
– – 0.05% 357
2025
Q3 		$3.53M Sell
68,054
-19,826
-23% -$967K 0.03% 493
2025
Q2 		$3.79M Buy
87,880
+14,356
+20% +$522K 0.04% 441
2025
Q1 		$2.54M Buy
73,524
+7,877
+12% +$266K 0.03% 626
2024
Q4 		$1.8M Buy
65,647
+21,024
+47% +$543K 0.02% 771
2024
Q3 		$1.14M Buy
+44,623
New +$1.17M 0.01% 736

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

INTECH Investment Management's BBIO Position: Q2 2026 in Review

INTECH Investment Management sold out of BridgeBio Pharma (BBIO) in Q2 2026, closing a stake of 43,857 shares — an estimated $3.26M sold.

INTECH Investment Management first reported a position in BBIO in Q3 2024 and held it in 7 quarters. The position peaked at $5.21M in Q4 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • INTECH Investment Management reported no remaining BridgeBio Pharma position as of Q2 2026 after selling out during the quarter.
  • INTECH Investment Management sold 43,857 BridgeBio Pharma shares in Q2 2026, an estimated $3.26M.
  • INTECH Investment Management first reported a position in BridgeBio Pharma in Q3 2024 and held it in 7 quarters.
  • INTECH Investment Management's BridgeBio Pharma position peaked at $5.21M in Q4 2025.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.